Beijing Amet was approved to set up a postdoctoral workstation
Release time:
2020-11-28 09:14
Source:
Recently, the Ministry of Human Resources and Social Security of the People's Republic of China and the National Postdoctoral Management Committee issued a document that approved the establishment of postdoctoral research stations by 497 units including the Advanced Technology Research Institute of the University of Science and Technology of China. in.
Our company is a high-tech enterprise specializing in the research and development of fully degradable implantable medical devices by using the independent innovation patent - 3D multi-axis precision printing technology. The product research and development of our company has been strongly supported by a number of scientific research funds such as the Ministry of Science and Technology, Beijing Municipal Science and Technology Commission, Zhongguancun Management Committee, Haidian District and Daxing District. Our company's 3D printed fully degradable coronary stent (trade name: AMSorbTM) has entered the clinical trial stage.
In addition, our company also has a workstation for academicians and experts, and has established close long-term cooperative relations with many domestic and foreign universities, scientific research institutions and clinical hospitals.
In the next step, our company will carry out post-doctoral training related work in a healthy, orderly and high-quality manner, accelerate the training of a group of innovative young talents in the field of domestic biodegradable medical device research and development, and contribute to the economic and social development of the capital.
Contact Us
Address: Building 11, Zhongguancun Medical Equipment Park, No. 26, Yongwang West Road, Daxing District, Beijing
Tel：010-6297-7955 E-Mail：amt@ametcorp.com
WeChat Contact
@Copyright 2022 Beijing Advanced Medical Technologies, Inc. All rights reserved
京ICP备11028039号 Powered by: www.300.cn SEO